Does Response Inhibition Have Pre- and Postdiagnostic Utility in Parkinson's Disease?

被引：13
|
作者：
MacDonald, Hayley J. [1 ,2 ]
Byblow, Winston D. [1 ,2 ]
机构：
[1] Univ Auckland, Dept Sport & Exercise Sci, Private Bag 92019, Auckland 1142, New Zealand
[2] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand
来源：
JOURNAL OF MOTOR BEHAVIOR | 2015年 / 47卷 / 01期
关键词：
Parkinson's disease; biomarkers; individualized treatment; response inhibition; impulse control disorders; CATECHOL-O-METHYLTRANSFERASE; IMPULSE CONTROL DISORDERS; DEEP BRAIN-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; RESONANCE-IMAGING MARKERS; MEDIAL PREFRONTAL CORTEX; BIMANUAL COORDINATION; DOPAMINERGIC MODULATION; VAL(158)MET GENOTYPE; 6-HYDROXYDOPAMINE LESIONS;
D O I：
10.1080/00222895.2014.941784
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
. Parkinson's disease (Pd) is the second most prevalent degenerative neurological condition worldwide. Improving and sustaining quality of life is an important goal for Parkinson's patients. Key areas of focus to achieve this goal include earlier diagnosis and individualized treatment. In this review the authors discuss impulse control in Pd and examine how measures of impulse control from a response inhibition task may provide clinically useful information (a) within an objective test battery to aid earlier diagnosis of Pd and (b) in postdiagnostic Pd, to better identify individuals at risk of developing impulse control disorders with dopaminergic medication.
引用
收藏
页码：29 / 45
页数：17
相关论文
共 50 条
  • [1] Improving Response Inhibition in Parkinson's Disease with Atomoxetine
    Ye, Zheng
    Altena, Ellemarije
    Nombela, Cristina
    Housden, Charlotte R.
    Maxwell, Helen
    Rittman, Timothy
    Huddleston, Chelan
    Rae, Charlotte L.
    Regenthal, Ralf
    Sahakian, Barbara J.
    Barker, Roger A.
    Robbins, Trevor W.
    Rowe, James B.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (08) : 740 - 748
  • [2] Atomoxetine restores the response inhibition network in Parkinson's disease
    Rae, Charlotte L.
    Nombela, Cristina
    Rodriguez, Patricia Vazquez
    Ye, Zheng
    Hughes, Laura E.
    Jones, P. Simon
    Ham, Timothy
    Rittman, Timothy
    Coyle-Gilchrist, Ian
    Regenthal, Ralf
    Sahakian, Barbara J.
    Barker, Roger A.
    Robbins, Trevor W.
    Rowe, James B.
    BRAIN, 2016, 139 : 2235 - 2248
  • [3] Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
    Ye, Zheng
    Altena, Ellemarije
    Nombela, Cristina
    Housden, Charlotte R.
    Maxwell, Helen
    Rittman, Timothy
    Huddleston, Chelan
    Rae, Charlotte L.
    Regenthal, Ralf
    Sahakian, Barbara J.
    Barker, Roger A.
    Robbins, Trevor W.
    Rowe, James B.
    BRAIN, 2014, 137 : 1145 - 1155
  • [4] Functional Deficits in Response Inhibition in De Novo Parkinson's Disease
    Vriend, Chris
    Gerrits, Niels J. H. M.
    Berendse, Henk W.
    Veltman, Dick J.
    van den Heuvel, Odile A.
    van der Werf, Ysbrand D.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 364S - 364S
  • [5] Functional correlates of response inhibition in impulse control disorders in Parkinson's disease
    Esteban-Penalba, Teresa
    Paz-Alonso, Pedro M.
    Navalpotro-Gomez, Irene
    Rodriguez-Oroz, Maria C.
    NEUROIMAGE-CLINICAL, 2021, 32
  • [6] PRE- AND UNPLANNED WALKING TURNS IN PARKINSON'S DISEASE - EFFECTS OF DOPAMINERGIC MEDICATION
    Conradsson, David
    Paquette, Caroline
    Lokk, Johan
    Franzen, Erika
    NEUROSCIENCE, 2017, 341 : 18 - 26
  • [7] Neural correlates of impaired response inhibition in the antisaccade task in Parkinson's disease
    Waldthaler, Josefine
    Vinding, Mikkel C.
    Eriksson, Allison
    Svenningsson, Per
    Lundqvist, Daniel
    BEHAVIOURAL BRAIN RESEARCH, 2022, 422
  • [8] Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease
    O'Callaghan, Claire
    Hezemans, Frank H.
    Ye, Rong
    Rua, Catarina
    Jones, P. Simon
    Murley, Alexander G.
    Holland, Negin
    Regenthal, Ralf
    Tsvetanov, Kamen A.
    Wolpe, Noham
    Barker, Roger A.
    Williams-Gray, Caroline H.
    Robbins, Trevor W.
    Passamonti, Luca
    Rowe, James B.
    BRAIN, 2021, 144 : 2513 - 2526
  • [9] Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
    Ye, Zheng
    Rae, Charlotte L.
    Nombela, Cristina
    Ham, Timothy
    Rittman, Timothy
    Jones, Peter Simon
    Rodriguez, Patricia Vazquez
    Coyle-Gilchrist, Ian
    Regenthal, Ralf
    Altena, Ellemarije
    Housden, Charlotte R.
    Maxwell, Helen
    Sahakian, Barbara J.
    Barker, Roger A.
    Robbins, Trevor W.
    Rowe, James B.
    HUMAN BRAIN MAPPING, 2016, 37 (03) : 1026 - 1037
  • [10] Pallidotomy does not ameliorate abnormal intracortical inhibition in Parkinson's disease
    Sale, M. V.
    Nordstrom, M. A.
    Brophy, B. P.
    Thompson, P. D.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (06) : 711 - 716
12345